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Abstract 
Tendon and ligament tissue engineering aims to provide an alternative tissue graft 
for patients with acute injuries that require surgical intervention.  Alternatives are 
necessary due to limited availability of allografts and autografts or other shortcomings 
in current biomaterial technologies.  Tissue engineering accomplishes this through the 
combination of three key components: a cell source, scaffold and mechanical or 
chemical stimulation.  While mechanical stimulation is the gold-standard for achieving 
tenogenic differentiation in progenitor cells, this work discusses many different 
methods of stimulation a differentiative response.  Additionally, a great amount of 
recent work has been done in the field of biomaterials, and discovering new materials 
that can be combined with cells and stimulation techniques to achieve a more suitable 
graft.  
 Additionally, further work is needed in optimizing the mechanostimulation 
regimen utilized in cultures. This work proposes a study in which shorter stimulation 
times are incorporated within more frequent rest periods to allow cells time to adapt and 
overcome refractory periods. Additionally, a new method of designing and producing 
bioreactors is proposed using fused deposition modeling, the most common 3D printing 
method, that allows for easy changing and rapid production of replacement parts. 






Tendon and ligament injuries are among the most prevalent injuries affecting 
both athletes and senior citizens.  Tendon and ligaments possess very limited healing 
capabilities, due to sparse cellularity and vascularity, and complete tears always require 
surgical intervention.  If the torn ends of the tissue cannot be sewn back together, a graft 
is taken from either a cadaver (allograft) or from a donor site in the patient (autograft).  
Both graft types contain major limitations such as limited availability, immune rejection 
and donor site morbidity.  With over 200,000 people in the US alone [1] requiring a 
graft annually, regenerative medicine is a promising alternative for patients.   
Tissue engineering and regenerative medicine seek to create suitable tissue 
replacements by utilizing one or any combination of the following: A cell source such 
as stem cells or primary fibroblasts, a biocompatible scaffold to provide mechanical 
support and replace lost tissue, and chemical or mechanical stimulation that drives cell 
growth or differentiation in a desirable manner.  By combining these components in 
vitro a suitable graft can be cultured, approximating the properties of native tissue. This 
graft can then be implanted at wound sites in vivo to allow faster and more complete 
recovery times. Tendon and ligament tissue engineering seeks to combine these 
concepts to the specific application of tendon or ligament replacements.  
For tendon and ligament tissue engineering, stem cells are commonly used as 
the cell source, as primary tenocytes or fibroblasts do not proliferate fast enough for 
conventional therapies.  One of the most difficult aspects of tendon and ligament tissue 
engineering is reliably differentiating progenitor cells and cell conditioning techniques 
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will be discussed in chapter 2. Additionally, the majority of recent work in the field has 
been in the investigation of new biomaterials for scaffold material which will be 
discussed in chapter 3. Lastly, future work and bioreactor design will be discussed in 
chapter 4.  
2. Cell Conditioning Techniques 
One major hurdle facing an alternative regenerative medicine therapy is being 
able to reliably condition precursor or primary cells in vitro prior to patient 
transplantation.  Cell conditioning techniques fall into broad categories: mechanical 
stimulation involving oscillatory stretching or sonic vibrations, chemical stimulation 
which involves growth factors or other cell signaling markers and lastly gene therapy 
where tendon/ligament genes can be directly added to precursor cells’ or proliferative 
genes can be added to primary cells.   
Ligament and tendon tissue are similar, but do possess some important 
differences that impact how cell conditioning will be carried out.  Tendons contain 
almost exclusively collagen type I with small amounts of collagen type III and elastin.  
Ligaments, while still mostly type I collagen have up to 10% collagen type III and a 
much higher elastin content.  Ligaments also possess a higher percentage of ground 
substance compared to tendons.  These differences in physical makeup allow ligaments 
to be much more elastic and handle forces in both lateral and axial directions, compared 
to tendons who largely handle loads in a single direction.  These differences allow a 
wide range of motion in joints without risking an acute injury every time we stretch and 
allows tendons to sometimes pull massive loads without tearing whenever we lift heavy 
objects.  Despite these differences, many studies use similar growth factors and 
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mechanical stimulation regimens, simply changing the starting cell line and scaffold 
material, hoping they can achieve the differences needed.   
Several important markers will be considered in evaluating the tendon or 
ligament like quality of a scaffold.  Mimicking the mechanical properties of natural 
tendons and ligaments is the most important metric to prevent new ruptures post-
surgery.  The mechanical properties of human tendons are extensively documented with 
tensile strengths ranging from 30 – 200 MPa depending on placement within the body 
and elastic moduli ranging from 1 – 2 GPa.  Tensile strength of human ligaments is 
similar but slightly less than that of tendons while elastic moduli range 200 – 300 MPa 
for most ligaments.   
Many studies working with progenitor cells examine the expression of tendon 
and ligament genes as a marker for differentiation.  COL-I and COL-III are two genes 
that regulate the production of collagen type I and collagen type III, the primary 
components of both tendons and ligaments.  The presence of SCX and TCN genes that 
code for scleraxis and tenascin-C respectively are examined in many studies.  Scleraxis 
is a unique early time marker for tenogenic differentiation.  Studies examining stem cell 
differentiation into tenocytes will generally see an early upregulation of scleraxis before 
it begins to fall in late term cultures.  Tenascin-C is a glycoprotein secreted by mature 
fibroblasts found in both tendons and ligaments and serves as a good late term marker 
of differentiation.  Tendons and ligaments both have a distinctive appearance 
characterized by dense regular connective tissue all aligned in a single direction; this 
makes it necessary for a majority of studies to include histological staining of tissue 
samples.   
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Another, more qualitative, method of examining scaffold quality is by 
histological staining to gauge fiber alignment, cellular migration and extracellular 
matrix (ECM) density.  Tendon and ligaments are both dense, regular connective tissues 
that have a very specific structure.  Collagen fibrils are woven into crimped fibers that 
are all oriented in one direction.  Additionally, these fibers do not traverse the full 
length of the structure and overlap and slide past each other.  These fibers are also very 
densely packed with cells sparsely distributed throughout.  The most popular method of 
staining is via hematoxylin and eosin (H&E) staining.  Hematoxylin is a basic stain that 
will bind to acidic compounds such as DNA/RNA, which will cell nuclei a bluish color.  
As a counter stain, eosin is acidic and will bind to positively charged amino-acid side 
chains on proteins, marking collagen fibers pink. H&E staining will clearly show fiber 
alignment which can be quantitatively examined using anisotropy computing tools.  
Cells are normally seeded on the surface of a scaffold, unless special fabrication 
techniques allow for interior seeding, so the depth cells have penetrated into the scaffold 
can also be learned from H&E staining.  Natural tissue is diffuse with cells so ensuring 
artificial scaffolds mimic this is important.  Lastly, many tissue engineering scaffolds 
are not as dense as natural tendon to allow for cells to more easily penetrate the tissue.  
The void space between fibers can be viewed as another method of qualitatively 
assessing scaffold quality.   
2.1 Mechanical Stimulation 
Mechanical stimulation is required to achieve tenogenic differentiation and even 
maintain tenogenic properties [2].  Utilization of mechanostimulation without growth 
factors yields differentiation, marked by an increased tensile strength of the scaffold and 
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upregulation of tendon related gene markers.  In the absence of any loading, tenocytes 
can dedifferentiate into immature fibroblasts, elucidating just how important structural 
loading is during conditioning [1].  The most common method of mechanical 
stimulation for tendon and ligament tissue engineering is through the use of a 
bioreactor.  One end of a construct can be anchored to a static base while the other is 
connected to some form of actuator.  While these bioreactors are almost always of a 
custom design, Bose manufactures a line of ElectroForce® bioreactors that can provide 
many different forms of mechanical stimulation to tissue constructs from simple axial 
stretch to full six degree-of-freedom movement.  There are multiple components to the 
stimulation potential tendon and ligament grafts will undergo that vary between studies 
and must be considered: oscillatory vs static, uniaxial vs multidimensional, intermittent 
vs continuous, frequency, force and duration are all important variables.  The values 
utilized for each variable are heavily dependent upon scaffold material and the 
robustness of the cell line.  Stronger materials require heavier loads to transmit the 
requisite strain onto the cells, conversely precursor cells such as stem cells are generally 
not as robust as fibroblasts or other primary cell types and too much strain can induce 
apoptosis prior to differentiation.  Frequencies for these studies range from 0.01 Hz to 1 
Hz while forces are generally reported as % strain and can range from 2-10% [3, 4].   
Wide variations in force can be seen throughout studies because forces applied 
to a scaffold do not equal the forces applied to the cells within.  The force cells 
experience is dependent on internal deformations of the scaffold utilized which is 
heavily dependent upon material architecture.  In natural tendons and ligaments, the 
method with which macroscopic forces are transferred throughout the interior is not 
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fully understood.  Additionally, collagen fibers possess a characteristic crimp pattern 
that dampens the force being transmitted.  Recent work suggests that shear forces of 
fibrils sliding past each other present the main mechanism of force transduction [5].  By 
isolating collagen fascicles from rat tails and examining them under confocal 
microscopy with uniaxial strain Szczesny et al.  was able to directly observe the fibers 
deforming and form a representative model of fibril strain [5].  This marked the first 
time such deformation was directly observed.  Better understanding of collagen force 
transduction will enable better designed mechanical stimulation regimes as strain 
induced apoptosis can be avoided.  In polymer scaffolds, force transduction varies 
wildly depending on the material and studies have to be discussed on a case by case 
basis.  Many scaffolds though consist of continuous spun fibers that traverse the length 
of scaffold, unlike the short sliding fibrils of collagen.  Forces applied to cells within 
those scaffolds would be subjected to deformations within the material making the 
estimation of the deformation more challenging than collagen fiber force loading.  
Specific studies comparing polymer force transduction to cell loading have not been 
conducted at this time and may need to be examined further in the future. 
Carefully controlling the mechanical forces is especially important in 
musculoskeletal organ conditioning.  Most progenitor cells are capable of 
differentiating down ligament, tendon, bone and cartilage lines depending on 
environmental cues.  Fluid shear forces tend to guide most adult stem cells towards the 
osteoblastic lineage [6] so encasing cells in the interior of a scaffold is a common tactic 
to avoid such stimuli.  Rotational forces applied to scaffolds during stretching can also 
greatly effect collagen deposition patterns.  Subjecting a scaffold to both axial and 
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rotational forces created collagen fibers that were helical in nature [4].  This pattern 
may reduce overall tensile strength in the axial direction since tendons almost 
exclusively experience unidirectional forces.  However, biaxial strain has been utilized 
with positive effects to create a construct with more ligament like qualities [7].  For 
example, a ligament study conducted by Lee et al.  used a regimen characterized by 
10% tension with 12mm elongation and torsion characterized by a 45° rotation in 
alternating directions; the requisite force for such elongations was not specified.  The 
constructs were subjected to this continuously for up to 7 days at a frequency of 1 Hz 
[8].  Their results showed an increased tensile strength of a decellularized tendon placed 
in a bioreactor without re-cellularization.  They found that the collagen bundles could 
reorganize in a more efficient pattern without cell specific remodeling emphasizing the 
importance of the mechanostimulation regimen scaffolds are subjected to.   
As an example of how wildly regimens differ, a study primarily concerned with 
the viability of tendon derived stem cells (TDSCs), found the ideal regimen for TDSCs 
to be 4% elongation at 0.5 Hz for 2 hr/day [9].  Utilizing this regimen yielded an 
ultimate tensile strength of 59.58 ± 7.81% of the original rabbit patella tendon they were 
targeting.  Additionally, increased deposition of collagen type I and III was observed 
with an upregulation in tenascin-C expression.  A supplemental study by the same 
group found that 8% elongation induced an inflammatory response in the TDSCs 
suggesting that over elongation mimics injury within tendons [10].  While this would 
appear to contradict the values utilized in the previously discussed ligament study, it is 
important to note that a decellularized scaffold void of cells was used in the ligament 
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study compared to a poly(L-lactide-co-ε-caprolactone)/collagen scaffold seeded with 
sensitive stem cells in the later study.   
The previously discussed studies have utilized relatively fast frequencies at 0.5 
and 1 Hz with either continuous or once a day stretching.  This does not reflect the 
loading patterns of most tendons and ligaments in the body and many studies have had 
positive results using slower frequencies with intermittent stretch periods.  Angelidis et 
al.  utilized alternating 1 hour periods of stimulation and rest at 1.25 N and 1 cycle/min 
[11].  The decellularized rabbit tendons utilized were seeded with either stem cells or 
fibroblasts.  After 5 days of culture in a bioreactor both groups exhibited no significant 
differences with natural tendons in either ultimate tensile strength or Young’s modulus, 
though the fibroblast seeded scaffolds had the highest tensile strength between 
experimental groups.  Using immunochemistry, they were also able to directly examine 
the cells elongating parallel to the direction of force, while unloaded scaffolds exhibited 
random orientation of cell nuclei with little elongation.   
Recent work has investigated the use of magnetic fields to apply mechanical 
stimulation, in lieu of a traditional bioreactor. By incorporating iron oxide particles in a 
scaffold, magnetic forces can be transmitted into a scaffold interior [12]. And while 
cytotoxicity and cell compatibility results are promising and cells did begin to 
upregulate some tendon related genes, it is unclear how magnetic stimulation compares 
to traditional mechanical stimulation, but it is a possible direction for future study.  
2.2 Gene Delivery 
An additional source of cell conditioning outside of the realm of normal growth 
factors and mechanical stimulation is the use of gene delivery to alter cell behavior 
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towards a desirable phenotype.  Since scleraxis is the only known marker of tendon 
progenitor cells it makes an easy target for gene delivery approaches.  One method is to 
use lentiviruses carrying the SCX gene to insert the gene into mesenchymal stem cell 
genetic material.  Statically culturing such MSC’s led to more elongated morphology 
with expression of COL-I and TCN [13].  Mechanically stimulating such MSCs led to 
the scaffold free creation of a tendon like collagen sheet that researchers were able to 
ectopically transplant into immune-deficient mice.  This eventually led to a dense 
connective tissue exhibiting a crimp pattern in the collagen fibers similar to that 
observed in natural tendons.  It is hypothesized that the overexpression of scleraxis 
causes blockage of the bone morphogenic protein (BMP) receptors that would 
sometimes drive cells down an osteoblastic pathway in culture.  Additional groups have 
taken SCX upregulated MSCs and injected them directly into wound sites of rat 
Achilles’ tendon [14].  These injections significantly improved the rat tendons healing 
capabilities and progenitors of the injected cells were shown to be at the wound site up 
to 16 weeks post-surgery.  Such promising results illustrate the importance of scleraxis 
upregulation in early cultures and could prove to be a promising step towards an 
artificial tendon graft.   
 Even though BMP-2 normally drives cells down an osteoblastic lineage, one 
group found that by engineering MSCs to co-express BMP-2 and Smad8, an 
intracellular protein involved in the transformative growth factor beta (TGF-) pathway, 
MSCs could be selectively driven towards a tenogenic lineage [15, 16].  Normally, 
injection of BMP-2 overexpressing MSCs at a wound site inevitably would lead some 
cells to undergo osteoblastic differentiation with bone being ultimately formed in the 
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wound site.  Any amount of calcification in a tendon is obviously unacceptable.  By 
taking BMP-2 expressing MSCs and forcefully upregulating Smad8, injection of these 
cells resulted in increased stiffness of the healed tendon, but not an increase in ultimate 
tensile strength or elastic modulus compared to non-modified cells.  Promisingly 
though, no calcium deposits were observed after 12 weeks.  The Gazit group 
hypothesized that Smad8 competitively inhibited the BMP-2 pathway [15].  The 
inhibition of this pathway and the blocking of the osteoblastic lineage achieved shorter 
recovery times.  Future work needs to be completed adding key variables like 
mechanical stimulation and an appropriate scaffold to further explore the viability of 
this approach.   
Overexpression of EGR1 in another study drove MSCs towards a tenogenic 
lineage [17].  EGR1 is normally a transcription factor with a variety of functions, but 
specifically in tendon healing Guerquin et al.  found that it functioned as a direct 
agonist for Col1a1 and Col1a2 promoters on MSCs and had an indirect effect on 
scleraxis production.  Additionally, in mice with the EGR1 gene knocked out, collagen 
fiber diameter was markedly reduced and the animal’s ability to heal from injury was 
diminished.  Evidence also suggests, that mechanical stimulation causes the expression 
of EGR1; further strengthening its role in tendon and ligament development [18].  As 
with the previously discussed gene delivery approaches, combinations of EGR1 
overexpression and mechanical stimulation with an appropriate scaffold need to be 
investigated further for possible use in tissue engineering strategies. 
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2.3 Chemical Stimulation 
 Chemical stimulation of cells for tendon and ligament tissue engineering relies 
on the intake of signaling molecules from culture medium.  Many utilized factors are 
cytokines such as fibroblast growth factor (FGF), growth differentiation factor (GDF), 
platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-.  
All of these chemicals have been observed directing in vitro progenitor cell cultures 
towards tendon-like or ligament-like phenotypes.   
2.3.1 TGF-
Transforming growth factor-beta (TGF) is part of a cytokine super family that 
performs a variety of functions in the body [19]. TGF- is seen throughout almost all 
stages of tendon healing but is most active during inflammation. It is known to help 
regulate factors such as cell differentiation and cell phenotype of tendon and ligament 
cells and induce expression of extracellular matrix proteins and stimulates production of 
collagen by tendon fibroblasts [20-22]. TGF- activates signal transduction through 
transmembrane serine/threonine kinase receptors which in turn leads to both Smad-
dependent and Smad-independent downstream processes [23].  
Several growth differentiation factors within the TGF- superfamily are 
involved in multiple important cell functions such as proliferation, differentiation, and 
extracellular matrix formation [24]. Specifically, GDFs-5, -6, and -7 are crucial 
participants in regulating tendon and ligament tissue development and the repair process 
[25-29]. These three GDF factors also form a sub group within the TGF- group that is 
known as the bone morphogenetic protein (BMP) gene family [30]. Growth factors are 
often used to direct and promote in vitro cell conditioning within biomaterials. The roles 
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of these growth factors on in vitro cell conditioning within biomaterials have been 
explored in several studies attempting to tissue engineer tendons and ligaments.  
Jenner et al. investigated the role of recombinant human transforming growth 
factor- 1 and growth differentiation factor 5 (GDF-5, also known as BMP-14 [31]) on 
human bone marrow stromal cells (BMSCs) cultured on woven, bio-absorbable, 3D 
poly(lactic-co-glycolic acid) scaffolds for ligament tissue development [32]. There were 
very limited differences between the two growth factors and their effect on tenascin-C, 
however, TGF-beta1 significantly improved production of collagen type 1 whereas 
GDF-5 was limited to only affecting cell proliferation. Ozasa et al. compared the effects 
of GDF-5 on muscle-derived stem cells (MDSC) and bone marrow stromal cells in an in 
vitro tendon healing model [33]. The tendons harvested were canine flexor digitorum 
profundus, and were seeded with MDSCs. The presence of GDF-5 maintained a 
significantly higher stiffness that may improve the outcome of tendon wound healing. 
Hayashi et al. utilized a collagen gel scaffold within a tendon healing model also 
consisting of canine flexor digitorum profundus tendon. The collagen gel was seeded 
with BMSCs and treated with GDF-5 [30]. At the end of 2 and 4 weeks, the 
combination of BMSCs with GDF-5 accelerated tendon healing activity, but the use of 
BMSCs without GDF-5 or the use of GDF-5 alone was not effective. 
Another approach for tendon tissue engineering used in a study by Vuornos et 
al. involves a braided polylactide copolymer filament scaffold seeded with human 
adipose stem cells. The goal was to treat the cells with GDF-5 and ascorbic acid for 
tenogenic differentiation. The study concluded that the growth factor with ascorbic acid 
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rapidly produced collagen and upregulated tenogenic gene expression markers after two 
weeks of culture [34].  
The effect of GDF-5 on cell proliferation and gene expression was investigated 
by James et al. on primary adipose-derived stromal cells (ADSCs) that were cultured on 
poly(DL-lactide-co-glycolic acid) PLAGA fiber scaffolds for tendon tissue 
development. The fibrous scaffolds were electrospun  mimicking, as close as possible, 
the microenvironment of the native tendon with GDF-5 supplemented in the culture 
medium [35]. At 7 and 14-day time points, cells that were maintained on PLAGA 
electrospun scaffolds showed increased cell proliferation when treated with 10ng/ml 
and 100ng/ml of GDF-5 when compared to 0ng/ml concentrations. Expression of 
collagen type I and scleraxis, were also significantly higher when treated with GDF-5.  
Growth differentiation factor-6 (also known as BMP-13) however did not show 
any improvement on a rat tendon model when overexpressed in MSC cells in a study by 
Gulotta et al. The results of this study did not demonstrate any differences in collagen 
formation or increase in biomechanical strength [36], likely ruling out GDF-6 for future 
studies.  
In studying tendon tissue formation, Lee et al. characterized the rat BMSC cell 
response to Growth differentiation factor 7 (GDF-7 also known as BMP-12). BMSCs 
were seeded onto 3D collagen sponge scaffolds before being treated with 10ng/mL of 
GDF-7 [37]. The effect of the GDF-7 treatment showed increased cell proliferation, 
elongation, and expression of tenascin-C as compared to scaffolds not treated with the 
growth factor.  
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Kishore et al. have investigated using the extracellular microenvironment to 
induce tenogenic differentiation of human MSCs. This is accomplished by synthesizing 
electrochemically aligned collagen threads that mimic the native tendon tissue [38]. The 
results show that tendon gene expression markers such as scleraxis and tenomodulin 
were significantly increased on these electrochemically aligned collagen threads 
compared to randomly sorted collagen threads despite a lower rate of proliferation. The 
lower proliferation rate was likely due to the cells differentiating down a fibroblastic 
pathway thereby lowering their proliferative capabilities. Next BMP-12 (GDF-7) was 
supplemented into the human MSCs medium to determine how well the scaffolds 
influenced tenogenic differentiation. There was no additional effect on tenogenic 
differentiation of the MSCs on the electrochemically aligned collagen thread scaffold 
with the inclusion of BMP-12, indicating that the scaffold itself has a lot of potential to 
be used as a source of tendon tissue replacement. 
2.3.2 FGF 
Basic fibroblast growth factor (bFGF) significantly affects fibroblasts, as can be 
seen by a dose-dependent increase [39] in cell proliferation and collagen type III 
production in rat tenocytes [40]. Subramony et al. designed a polylactide-co-glycolic 
acid (PLGA) nanofiber-based scaffold that resembles the native ligament extracellular 
matrix for ligament regeneration [41]. Human mesenchymal stem cells (hMSC) were 
primed in vitro with basic fibroblast growth factor (bFGF) to enhance ligament cell 
formation prior to the application of mechanical stimulation. The PLGA scaffolds were 
produced using electrospinning. MSC response to chemical stimulation was measured 
by cell growth and collagen content. The results of this study show that there was an 
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increase in cell proliferation due to cell treatment with bFGF and upregulation of types I 
and II collagen, fibronectin and tenascin-C on the nano-fiber meshes. Sahoo et al. 
reported similar findings when utilizing bFGF to stimulate MSCs on silk/PLGA hybrid 
fiber scaffolds for ligament regeneration [42, 43].  
Petrigliana et al. investigated the use of a bFGF-coated, three-dimensional (3D), 
polymer scaffold for ligament tissue engineering [44]. 3D porous polycaprolactone 
(PCL) scaffolds treated with bFGF at doses of 0 ng, 100 ng, and 500 ng were seeded 
with bone marrow stromal cells (BMSCs) and cultured under static conditions. An 
increase in collagen I, collagen III, and tenascin-C were seen at 24 hours, 7 days, and 21 
days. The effects of low dose (3 ng/ml) fibroblast growth factor 2 were demonstrated by 
Hankemeier et al. on the cell proliferation and differentiation of BMSCs for the tissue 
engineering of tendons and ligaments. It was shown that in the presence of a low dose 
of bFGF, collagen I, collagen II, and smooth muscle actin were enhanced at a higher 
level compared to the exposure to a higher dose of bFGF [45].  
RGD-modified silk fiber matrices seeded with BMSCs were examined by 
Moreau et al. These matrices were cultured with bFGF or epidermal growth factor 
(EGF) prior to mechanical loading in this study. Stimulating the BMSCs with bFGF for 
five days showed modulated protein expression in the silk fiber scaffolds as well as 
increased cell activity and tissue development compared to the scaffolds primed with 
EGF [46]. All samples treated with bFGF or EGF were then treated with transforming 
growth factor-beta (TGF-). All non-control samples showed significant in vitro 
ligament development by day 14 on the silk fiber scaffolds [47]. Additionally, by 
sequentially introducing bFGF and TGF-β3 and IGF-I, one group was able to expand 
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primary cultures in vitro for longer culture times than previously achieved [48]. 
Combination of this regimen with a silk scaffold resulted in tensile strengths higher than 
that of native tendons.  
Wodewotzky et al. seeded canine multipotent mesenchymal stromal cells on 
collagen membranes treated with or without hyaluronic acid for tendon tissue 
regeneration. The benefit of bFGF was also investigated. In all cases, the scaffolds 
treated with bFGF significantly increased the proliferation capacity of the mesenchymal 
stem cells [49]. An in vitro wound closure model was investigated by Chan et al. to 
determine the effect of bFGF on the response of cultured rat patellar tendon fibroblasts. 
The wound model was treated with 2 ng/mL of bFGF and showed enhanced cell 
proliferation, while an increased bFGF concentration showed little improvement [50]. 
2.3.3 IGF-I 
Insulin-like growth factor has been found to increase collagen production in 
various tendon and ligament models and is involved in the matrix synthesis of wound 
healing. DesRosiers et al. treated canine anterior cruciate ligament fibroblasts with IGF-
1. The study showed how IGF-1 stimulates fibroblast proliferation and extracellular 
matrix synthesis [51].  Hortensius et al. seeded human mesenchymal stem cells from 
human bone marrow onto collagen-glycosaminoglycan scaffolds supplemented with 
IGF-1. Sulfated glycosaminoglycan on the scaffold was more likely to bind to IGF-1 
than non-sulfated, affecting overall cell attachment and activity [52]. Murphy et al. 
examined the effects of IGF-1 on tenocyte activity within superficial digital flexor 
tendon explants. IGF-1 increased collagen synthesis for types I and III [53].  
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Caliari et al. examined the effects of PDGF-BB and IGF-1 to treat primary horse 
tenocytes cultured on anisotropic collagen-GAG scaffolds for the purpose of tendon 
tissue regeneration. It was found that although pore size affected cell distribution 
throughout the scaffold after 14 days, overall, the use of either PDGF-BB or IGF-1 
significantly improved tenocyte cell proliferation and cell attachment. However, PDFG-
BB dose of 100 ng/mL exhibited a much higher tenocyte cell metabolic activity than 
IGF-1 [54]. 
2.3.4 Other 
It can also be noted that scaffolds with functionalized with biomolecules have 
also been shown to affect in vitro cell conditioning. Sahoo et al. developed three 
versions of an electrospun hybrid polymer scaffold to determine if scaffold coating 
techniques could facilitate cell attachment and proliferation [55]. Knitted scaffolds were 
coated with either a thin film of poly(E-caprolactone) (PCL), poly(DL-lactide-co-
glycolic acid) (PLGA), or using a film of collagen type I. Each scaffold was seeded 
with porcine bone marrow stromal cells (BMSCs) with cell proliferation notably larger 
on the PLGA and collagen I coated scaffolds. Liu et al. used knitted silk scaffolds 
seeded with human bone marrow-derived mesenchymal stem cells (hMSCs) with and 
without fibrin gel to study the effects for ligament tissue engineering. It was found that 
the fibrin gel increased cellular function when analyzed for collagen types I and III and 
tenascin-C gene markers [56]. Seo et al. also compared the use of a silk scaffold with a 
composite silk scaffold containing a lyophilized collagen-hyaluronic acid substrate. 
Rabbit tenocytes were seeded onto the scaffolds and cultured in vitro. Cell density was 
significantly larger on the composite silk scaffold after 30 days [57]. The effect of fiber 
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chemistry and braiding angle of scaffolds was investigated by Czaplewski et al. for 
regeneration of tendon and ligament tissue. After braided submicron fibrous scaffolds 
were developed, they were seeded with human induced pluripotent stem cell-derived 
mesenchymal stem cells. The stem cells were not supplemented with tenogenic medium 
[58]. It was found that the cell lineage and cell adhesion was affected by the fiber 
chemistry and braiding angle. Larger scaffold braided angles had a higher likelihood for 
tenogenic differentiation.  
 Similar to coating scaffolds in bioactive molecules, embedding growth factors 
within a polymer to be released through controlled degradation is a common strategy 
for in vivo growth factor delivery. Stromal cell-derived factor-1 (SDF-1 alpha) was 
investigated by Shen et al. as a method of in vivo cell recruitment. SDF-1 alpha is a 
cytokine that regulates stem cell migration and cell recruitment during inflammation 
[59, 60]. SDF-1 alpha was incorporated within a knitted silk-collagen sponge scaffold, 
and three cell sources were used including rate bone mesenchymal stem cells (BMSCs), 
hypo-dermal fibroblasts (HDFs), and Achilles tendon fibroblasts (ATFs). Each cell line 
was treated with 200 ng/mL within the scaffold [61]. Gene markers sensitivity varied 
among the three cell sources. BMSCs and HDFs markers for cell migration and CXCR4 
responded to SDF-1 alpha more than ATFs, whereas ATFs gene marker for tendon 
repair showed more sensitivity. Additionally, migration of fibroblast like cells increased 
while accumulation of inflammatory cells decreased after scaffold implantation into 
injured rats. Evidence was also found that suggested SDF-1 increased collagen I 
deposition, further increasing implanted scaffold quality. SDF-1 alpha was also 
examined by Caliari et al. among other growth factors. Equine tenocytes were cultured 
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onto aligned anisotropic collagen-GAG scaffold for use in tendon tissue engineering. 
SDF-1 alpha had a positive effect on tenocyte cell migration, collagen synthesis, and 
tendon gene expression [62]. Tenogenic differentiation is enhanced by anisotropic 
scaffolds when compared to a standard control [63].  
 Musson et al. evaluated the novel use of non-mulberry silk fibrin scaffolds 
(Spidrex) for tendon regeneration. Spidrex was seeded with primary human or rat 
tenocytes and compared with a knitted bombyx mori silk scaffold, 3D collagen gel, and 
fiberwire. Rat tenocytes cultured on Spidrex had an increased expression of tenogenic 
genes (fibromodulin, scleraxis, and tenomodulin) supporting the scaffold for use in vivo 
applications [64]. 
2.4 Other Cues 
 A common strategy is the use of pre-aligned fibers to promote ECM deposition 
in the same direction and cell expansion along set guidelines. This is especially 
important in polymer fiber scaffolds as the fibers will naturally acquire a random 
orientation, but by aligning all the fibers in the same direction an increase in mechanical 
strength can be achieved, while the presented topographic information may induce 
differentiation [65, 66]. Stem cells cultured on an aligned poly-L-lactic acid (PLLA) 
scaffold exhibited upregulation of scleraxis at day 3 compared to a scaffold with 
randomly oriented fibers. At day 7 the scaffold with randomly oriented fibers began to 
show upregulation of osteocalcin and ALP indicating an osteoblastic lineage. No other 
stimulation was provided beyond fiber orientation, emphasizing how important that can 
be. Additionally, culturing cells on the aligned fibers with osteogenic induction media 
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limited the production of osteoblastic markers below levels normally observed. Similar 
effects can be seen with the use of 3D printed aligned fibers in a collagen gel [67].  
 It’s important to note that two-dimensional topography can be important but 
does not translate directly into in vivo models. English et al. examined the use of 
aligned grooves in a cell culture substrate to induce tenogenic differentiation and found 
that ~2 micron deep groves could induce tenogenic differentiation in 2D cultures [68]. 
But, implantation of these scaffolds failed to yield positive tissue repair compared to 
randomly oriented 3D scaffolds. Further work is necessary to elucidate the effect of 3D 
substrate topography in tendon regeneration in vivo.  
 Cell seeding density can also have a drastic effect on ultimate cell outcome, 
especially when cells are enclosed within a scaffold to block shear forces. Issa et al. 
conducted a study utilizing human umbilical veins (HUVs) as a scaffold material and 
found no growth in cell numbers at high seeding densities (10 million cells/mL) along 
with high numbers of lysed cell bodies [69]. Conversely at low seeding densities (3 
million cells/mL), cell numbers increased exponentially after just a single week. 
Additionally, an investigation into the mass transport limitations of the scaffold found 
that no molecules over 20 kDa could penetrate through the scaffold to the interior where 
cells resided. Veins have a similar physical makeup to tendons and ligaments however 
they are less dense with a much greater concentration of elastin. With that in mind, a 
mature tendon/ligament most likely experiences even greater mass transport limitations 
than those seen by Issa. However, tendon stem cells have been observed performing 
better under hypoxic conditions [70]. So there are benefits to having mass transport 
limitations. Knowledge of this nutrient deficiency should be incorporated into future 
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study designs as both a potential pitfall and boon for maintaining stem cell proliferative 
qualities for longer durations.  
3. Biomaterials 
The majority of recent work in the field of tendon and ligament tissue 
engineering has focused on biomaterials.  Because of the high demand for natural 
tissues, it may be more feasible to turn to alternative materials for grafts.  Decellularized 
tendons, be it from human or animals, are not normally utilized as scaffolds because 
their dense collagen does not allow adequate penetration for recellularization and other 
natural tissues can vary wildly in physical properties.  However, customized 
collagenous scaffolds are a promising alternative to these native tissues [71]. The 
simplest application of collagen scaffolds is the application of a sponge at an injury site.  
One group has examined the use of a simple acellular collagen type I sponge in a rat 
model of tendon injury [72].  Working under the hypothesis that healing tendons will 
resorb and incorporate surrounding collagen, a 3 mm x 2 mm x 1 mm collagen sponge 
was implanted at the site of an Achilles tendon transection.  While after 4 weeks, both 
control and sponge group had the same strength, the sponge group had reached 
functional strength at the 2-week mark, a marked increase in recovery time.  One group 
used a similar sponge that was seeded with tendon derived cells [73]. In vitro cultures of 
the sponges yielded promising results but further study is necessary, possibly through 
the inclusion of a bioreactor for mechanostimulation during culture.  
Further sophistication of collagen scaffolds can be reached by aligning the fibers 
specifically.  One group recently investigated different manufacturing methods to create 
aligned collagen scaffolds for MSC culture [74].  By dialyzing collagen against PEG 
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and then polymerizing the collagen in different ways they were able to create different 
levels of reproducible alignment in the scaffolds.  One of the most interesting findings 
was that the fibers on the boundaries were generally not aligned, suggesting boundary 
conditions can control the alignment of collagen fibers.  Unfortunately, this work was 
mostly done in 2D scaffolds targeting bone tissue grafts, but their results could be 
transferred to tendon and ligament tissue engineering.  MSCs cultured on their scaffolds 
were shown to spontaneously orient themselves in with the direction of the fibers.  
Further investigation could yield scaffolds suitable for tendon and ligament grafts.   
 Combining collagen with other biomaterials allows for high biocompatibility 
while possibly circumventing some of the structural weakness a pure collagen scaffold 
might possess.  In one recent study, a collagen, 1,4-butanediol diglycidyl ether 
(BDDGE) and elastin gel (CBE gel) membranes were fabricated and then braided 
together to produce a strong inner structure.  This braid was coated in a CBE gel tube 
that had axially aligned pores produced through specific freezing and freeze-drying to 
guide cellular migration [75].  This scaffold was seeded with MSCs and implanted in a 
rat Achilles heel model to determine safety and efficacy. Mild improvements were 
observed in rats’ healing 8 weeks post-surgery, more refinements are needed before the 
material is ready for human trials. Specifically, the outer shell was too large to be 
implanted in the rat model, so only half the scaffold was available for in vivo analysis. 
Similar multi-layer scaffolds have had promising results [76], and future work is needed 
in this area. 
 One popular method of scaffold fabrication is via electrospinning. 
Electrospinning uses electric forces to draw out charged fibers with diameters in the 
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nanometers. These fibers can then be woven together in such a manner that somewhat 
emulates the structure of collagen in tendons and ligaments making it a popular tool. 
Recently, an electrospinning process has been developed that will allow for crimped 
PLA fibers [77]. These crimped samples exhibited ultimate tensile stresses roughly 
double that of the un-crimped samples. This production technique was compatible with 
tendon fibroblast cultures, and could pave the way for a new paradigm of biomimetic 
materials. Another group, has developed a method to anisotropically align electrospun 
fibers into sheets that are then woven into tubular structures for tendon scaffolds [78]. 
Another method of electrospinning involves co-spinning different polymers together, by 
spinning poly(-caprolactone) and methacrylated gelatin together, one group achieved 
tenogenic differentiation after treatment with TGF-β3 along with promising physical 
properties [79]. And while these groups demonstrated cell penetration, many 
electrospun scaffolds exhibit poor cellular penetration as a result of limited porosity. To 
counter that, one group has developed a novel electrospinning technique that creates 
anisotropically aligned scaffolds with controllable porosity out of poly(-caprolactone) 
[80]. Electrospinning fibrous scaffolds looks to be a very promising method of scaffold 
formation as the field moves forward.  
 One of the largest issues facing tissue engineering strategies and current surgical 
therapies is the lack of a tendon-bone interface [2]. Current surgical methods involve 
mechanical fixation of a tendon to bone and have a higher and desired re-failure rate. 
The challenges of designing a material with such a wide range of properties are 
numerous, but recent work has been done to create these osteotendinous scaffolds.  
 
24 
4. Research Plan 
4.1 Bioreactor Redesign 
4.1.1 Rapid Prototyping Design 
Bioreactors are integral in 
tendon tissue engineering.  Many 
custom bioreactors are made out of 
interchangeable modules to facilitate 
easy cleaning and replacement.  Our 
own bioreactors seen in Figure 1, 
consist of an acrylic base with 3 
chambers for a scaffold to reside that 
can be filled with culture medium.  The 
tops of the chambers are sealed with 
latex to allow for stretching and 
attached to a linear voice coil motor 
which is controlled by a digital signal 
generator.  These units are unfortunately 
hard to service, as the glass and acrylic 
pieces are custom made.  The glass 
tubes have custom nipples blown onto 
the top and bottom to allow for tube 
attachment and facilitate media 
circulation.  These nipples are quite 
Figure 1: Bioreactor System 
 
Previous bioreactor system in which the 
custom glass resevoirs and acrylic base can 
be clearly seen.  The tops are sealed with 
latex that is secured with dual 3mm zip ties.  
The hooks are connected to a linear voice coil 
motor (not pictured). 
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fragile and if broken, the entire unit had to be scrapped.  Additionally, we lack the in-
house instruments to fabricate either these tubes or the acrylic bases.  All of these 
factors combine to cause quite long repair times if we need to source replacement parts.   
In an effort to reduce down time in the event of a malfunction, 3D printing has 
the potential to complete replace our dependence on outside products.  Specifically, 
fused deposition modeling (FDM) can be utilized to create new, easily replaceable parts 
for bioreactor systems.  And, while it would be easiest if all pieces could be created 
using FDM, complete replacement of the glass pieces is unfortunately impossible as a 
Figure 2: Sketch of Bioreactor Base 
This is the lowest level of the Solidworks® sketch used to create the new bioreactor 
bases. The anchoring holes are laid out equidistant from the center along the 3 primary 
axis. The dimensions are related such that increasing one will increase the dimensions 
of all other parts. 
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viewing window is needed, so at least some glass tubing needs to be incorporated.  For 
the FDM pieces, multiple criteria had to be taken into account, mainly, scalability, 
water-tightness and mass producible.   
The parts need to be scalable to accommodate possible alternative scaffold 
materials.  While our normally utilized HUV scaffolds have a uniform diameter, our lab 
is examining future work involving other scaffolds that possess different physical 
dimensions so easily tunable pieces are desired.  This is easily obtained by relating 
Figure 3: Bioreactor Base – Dock for Tubing 
These concentric circles represent the docks that glass tubing can be inserted into in the 
bioreactor. Current dimensions are 20 mm in diameter with a 5 mm wall thickness.   
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dimensions within SolidWorks®.  In Figure 2, the starting sketch can be seen where 
each anchoring hole is set 
along a primary axis, 
equidistant from each other.  
Additionally, the dimensions 
are visible, so that it can be 
roughly seen how each 
dimension is related to each 
other.  Equations are utilized 
such that if one dimension is 
changed, each other 
dimensions will adjust itself 
accordingly, leading to easy 
scaling of the part.  This base 
is then extruded 1 cm to create 
a foundation for the bioreactor.  
On top of that foundation, a 
dock is created that glass 
tubing can be inserted to allow 
viewing of the samples.  These are extruded 20 mm up to allow for secure glass 
insertion and room for media feed tubing.  To create the media tube adapter, an 
additional sketch plane (Figure 4) was created offset from the front of the reactor by 
about 1 cm.  Using this new plane, holes were cut through a single body to ensure full 
Figure 4: Bioreactor Sketch – Extra Plane 
The new drawing plane can be seen in front of the 
glass tubing docks. Circles were cut through the 
docks using this plane to create an interface for 
media tubing.  
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clearance.  These holes were centered using 
the dimensions of the base such that if the 
base changes dimensions, the holes will stay 
centered on the docks.  The holes were cut 
to accommodate luer lock 1/8” tubing 
connecters from Cole Parmer Instrument 
Company, but can be sized to accommodate 
most common tubing connectors. Also 
visible in Figure 4 is the lip cut into the top 
of the docks seat glass tubing into.  The 
shelf is equal to the wall thickness of the 
glass tubing utilized to create a uniform 
interior on the inside.  
While the glass tubing can be inserted into these docks and culture medium can 
flow into the chambers from the bottom, a top connector is needed to allow outflow and 
a secure place to attach our latex to ensure an enclosed system.  The top pieces were 
designed (Figure 5) similarly to the bottom docks just discussed. They possess an inner 
shelf the same width as the glass wall thickness, a hole cut the size of a luer-lock 1/8” 
tubing adapter, but additionally have a chamfered insert on the top.  This insert is 5 mm 
wide to allow for a 3mm zip tie to set comfortably inside it, and chamfered to ensure no 
sharp edges can cut the latex.  This insert allows for a more reliable seal than the 
original design.  
Figure 5: Bioreactor Sketch – Top 
Top piece of bioreactor designed with a 
shelf for secure fitting on glass tubing, a 
hole for media tube connection, and a 
top chamfer for latex sealing. 
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 These parts were then 3D printed using a MakerBot Replicator 5th Generation 
printer.  They were printed using “Natural” PLLA filament spools obtained from 
MakerBot.  This PLLA filament is dye free and easily sterilized for use in cell culture 
applications.  Unfortunately, without post-processing, 3D printed objects are generally 
quite porous and not water-tight, one of the original requirements.  Several different 
sealant methods were tested, including silicone caulking and several different epoxies.  
For silicone, a layer was applied on interior surfaces using a cotton tipped applicator 
and allowed to dry for 24 hours.  Water was then allowed to flow through the pieces for 
Figure 6: 3D Printed Bioreactors 
Left: Bioreactor pieces coated in XTC-3D, sealed and filled with culture medium. 
Pieces are leak-proof, the color seen at the top and bottom of the glass pieces is simply 
because the 3D printed pieces are slightly translucent. Right: Same pieces without top 
seals and no culture medium, the adapters for tubing are clearly visible. Some running 
of the epoxy is inevitable during drying.  
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at least 24 hours and examined for leaks. Silicone alone proved inadequate to seal these 
pieces as some sprang leaks immediately.  
 The same technique was used to test epoxy mixtures. Specifically, XTC-3D an 
epoxy manufactured by Smooth-On Inc. and advertised as a way to seal 3D printed 
objects easily. XTC-3d was mixed according to manufacturer instructions and an even 
layer was applied to all surfaces. Glass tubing and media tubing connecters were 
inserted and allowed to dry into the epoxy for a secure connection (Figure 6). Pieces 
were again allowed to dry for 24 hours. After drying, pieces had to be as a large lip had 
formed on the lowest edge of the pieces. Water was then allowed to flow through the 
objects for 24 hours. After 24 hours, XTC-3D coated pieces exhibited no leaking and 
were sterilized for testing in cell culture.  These new bioreactors were then setup using 
the normal protocol laid out in section 4.3 Materials and Methods. Preliminary results 
utilizing the new bioreactors revealed no deviations from past results.  
4.1.2 Electronic Signal Generator 
 Previously a Wavetek 185 Sweep Function Generator was used to generate a sin 
wave at 0.017 Hz and a calibrated amplitude to generate the necessary waveform for 
our mechanical stimulation.  After noticing irregularities in the stimulation, I connected 
the signal generator to a signal analyzer to verify the sin wave. I began the test at 100 
Hz and worked down to the requisite 0.01 Hz. At 100 Hz, the signal is verifiably a sin 
wave, but below that the signal devolved into noise. This evidence can be seen in 




4.2 Research Proposal 
Previously discussed studies in Section 2.1 Mechanical Stimulation did little to 
no optimization work on the duration of their mechanostimulation.  At most two 
separate time groups were examined and the most beneficial group was chosen.  Some 
optimization studies have been carried out though.  Youngstrom et al.  studied the effect 
of different strains using decellularized porcine tendons at 0.33 Hz and 1 hr/day [81].  
Their results show that 3% strain was the optimum for use in the decellularized tendon 
scaffold.  Higher strains of up to 5% began to lower mRNA expression of collagen type 
I and II genes and also led to an ultimate decrease in tensile strength that was 
significantly lower than the 3% strain group.  Additionally, recent evidence suggests 
that shorter intermittent durations can lead to more tendon like qualities because they 
avoid habituation of signaling pathways [82].  Mechanical stimulation is hypothesized 
to activate the ERK1/2 signaling pathway within cells which in turn promotes collagen 
deposition and ECM remodeling.  Paxton’s group found that ERK1/2 phosphorylation 
fell off sharply after 10 minutes of stimulation and that neither frequency nor force had 
any effect on ERK1/2 activity.  In a ligament model using mature fibroblasts, the ideal 
regimen was found to be 10 minutes every 6 hours at 0.5 Hz with no significant 
differences observed between 2.5%, 5% and 10% strain.  The absence of a strain effect 
is likely due to mature fibroblasts being able to withstand greater strains than progenitor 
cells.  The discovered refractory period could lead to a new paradigm of mechanical 
regimens that will greatly improve future results. 
Cellular habituation to stimuli is a well-documented phenomenon in which cells 
stop responding to a stimulus that is repeated or maintained for too long [83-88].  The 
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majority of the investigation into cellular habituation has been conducted on plant cells, 
and what work has been done on mammalian lines is predominately conducted in 
neurons.  But, as the work above by Paxton illustrates, other mammalian lines exhibit 
habituative behavior to extended stimuli.  And while ligament fibroblasts are extremely 
similar to tenocytes, many differences have already been pointed out.  
I have hypothesized that breaking the mechanostimulation regimen up into short 
time frames will significantly increase the tendon-like phenotype of a tissue engineered 
scaffold.  While cellular differentiation pathways are not well understood, whatever 
pathways are being activated by mechanical stimulation likely behave similar to ERK 
and other documented cell responses, and stop activating after short periods. These 
short stimulation periods, followed by frequent resting periods will allow cellular 
pathways to overcome any refractory periods to achieve a scaffold more suitable for 
patient implantation.   
For analysis, cell numbers will be collected to determine viability of culture 
methods utilizing a dsDNA assay. Gene expression will be examined using the 2-Ct 
method of comparing experimental genes to the housekeeping gene GAPDH. Several 
ECM genes will be examined to determine if matrix is being deposited, as well as 
multiple tendon specific genes. Lastly, several genes representative of undesirable cell 
lines will be examined to verify the absence of those lines. These are labeled as such in 
Table 2. The ultimate tensile strength of our constructs will also be collected for 
comparison to native tendons.  
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4.3 Materials and Methods 
4.3.1 Scaffold Preparation 
 Discarded human umbilical cords were obtained from Norman Regional 
Hospital (Norman, OK) with approval by the local Institutional Review Board.  The 
human umbilical vein (HUV) was then extracted from the cord using a computerized 
lathe.  The whole umbilical cord is mounted on a steel mandrel and frozen overnight at -
80°C.  The frozen tissue and mandrel is then inserted in a computerized lathe which 
removes the extraneous Wharton’s Jelly and leaves a diameter of 6.75 ± 0.25mm and a 
wall thickness of 0.75 mm.  Samples were then cut to 6.5cm for bioreactor insertion.   
 After extraction, the HUV was inverted so that lumen of the vein was on the 
exterior for superior cell attachment.  The inverted HUV is then washed in 1% sodium 
dodecyl sulfate (JT Baker, Center Valley, PA) for 24 hours to begin the 
decellularization process.  Followed by DI water washes of 10 min, 20 min, 30 min and 
24 hours and then a 24 hr wash in 70% EtOH to remove any remaining SDS in the 
HUV interior.  This is followed by 10 min, 20 min and 30 min of water washes and then 
a 2 hr wash in 0.2% per-acetic acid (Sigma Aldrich, St.  Louis, MO).  Post-acid wash 
the HUVs were washed in 10 min, 20 min, 30 min and overnight DI water washes to 
remove residual acid from the cords before finally undergoing a 24 wash in phosphate 
buffer of 7.2 – 7.4 pH.  Cords were then stored for no longer than 1 week at 4°C before 
bioreactor insertion.   
4.3.2 Cells 
 Bone marrow MSCs were utilized for all experiments.  Male Wistar rats of 175 
– 199 g in mass were obtained from Envigo and processed using previously established 
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protocols approved by the local IACUC board.  Rats were asphyxiated one at a time by 
filling a sealed chamber with CO2 at a rate of 10% of the chamber volume per minute.  
Between each rat, the chamber was purged of excess CO2 to prevent the animals from 
becoming frightened and to prevent early asphyxiation.  After death is confirmed, each 
rat is shaved from mid-body down and submerged in 95% EtOH for ~10 min for 
sterilization.  The rats were then placed into a surgical area and the surgery site is 
scrubbed with Triadine™ and 95% ethanol to ensure sterilization.  After isolating the 
surgical site, the skin is split from hip to ankle to allow access to the femur and tibia 
which are resected and cleaned of any connective tissue and muscle before being rinsed 
with serum-free α-mem.  Rinsed bones are cut open and an 18-guage needle is inserted 
into the marrow cavity.  Using ~5 mL of α-MEM, the marrow is flushed from the bone 
and collected in a conical vial.  Marrow collected from all bones was then homogenized 
and distributed between T-75 cell culture flasks.  Media volume within the flasks is then 
brought up to 10 mL and the flasks are cultured in a humidified incubator at 37°C and 
5% CO2.  5 days post-extraction, the media was removed from the flasks and the cells 
were rinsed with phosphate buffered saline (PBS) before having fresh media added.  
This rinse is to remove any non-adherent cells in the flasks such as hematopoietic stem 
cells and erythrocytes.  The remaining adherent are passage zero rat MSCs.  Passage 2 
cells were utilized for all experiments.   
4.3.3 Experimental Design 
 To prepare the tissue constructs for bioreactor insertion, MSCs were mixed with 
2 mg/mL of collagen type I at a density of 1 million cells/mL following manufacturer 
instructions for a collagen hydrogel.  0.6 mL of this cell/collagen mixture was then 
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injected into the HUV interior and sealed at both ends with custom stainless steel 
adapter which are clamped 5 mm from the ends with 3 mm zip ties.  The constructs 
were then placed in supplemented α-MEM and incubated at 37°C for 2 hours to allow 
for collagen cross-linking.  After the cross-linking, constructs were placed into the 
bioreactor using custom hooks and attached to a uniaxial motor.  These constructs are 
cultured for 7 or 14 days for various durations.   
 Mechanical stimulation was applied daily to the constructs 
following the groups described in Table 1: List of experimental 
groups 
All experimental groups experience a total of 1hr/day of stimulation at 2% strain and 
0.017 Hz with varying rest periodsTable 1.  All groups are subject to 2% strain at 0.017 
Hz and the stimulation intervals add up to 1 hour total of stimulation per day with 
differing rest periods.  All samples were held at a calibrated 1% strain during rest 
periods [69].  The control was a group subject to the resting 1% strain but no dynamic 
stimulation.  Post-culture the constructs are removed and prepped for specific analyses.   
 
Stimulation Time (min) Times/Day Strain Frequency (Hz) 
60 1 2% 0.017 
30 2 2% 0.017 
15 4 2% 0.017 
10 6 2% 0.017 
5 12 2% 0.017 
 
Table 1: List of experimental groups 
All experimental groups experience a total of 1hr/day of stimulation 




4.3.4 Mechanical Analysis 
 A uniaxial tensile testing frame (Untied Testing Systems, model SSTM-2K, 
Flint, MI) was used for mechanical testing.  Whole, cylindrical, wet constructs were 
utilized for analysis.  Samples were preconditioned for 5 cycles to remove hysteresis 
and then underwent analysis at 1%/sec until failure.  Displacement and force was 
recorded by companion software and used to calculate stress, strain and elastic modulus 
for each construct.  To avoid end effects of the samples and clamps used, only samples 
that fail away from the end regions will be included in analysis.  Samples for 
mechanical analysis are separate from other analysis methods.   
4.3.5 Cell Proliferation 
 Using a separate construct, a 0.5 cm section was removed from the top, middle 
and bottom of the construct.  These samples underwent incubation overnight in 300 
U/mL of collagenase type I in PBS to facilitate ECM break down.  Samples were then 
sonicated for 15 seconds and frozen at -20°C.  Samples were then thawed and refrozen 
2 more times to facilitate further cell lysation and release of DNA content into solution.  
The resulting solution was analyzed utilizing a Quant-iT™ PicoGreen dsDNA Assay kit 
(Life Technologies) to assess the solution’s fluorescence at 480/520 nm 
excitation/emission wavelengths.  The resulting DNA concentration was then converted 
to a cell number using a pre-measured DNA content per cell of 7 pg/cell.   
4.3.6 Histology 
 For histological staining, 0.5 cm sections were fixed in 10% formalin (Azer 
Scientific, Morgantown, PA) and embedded in paraffin (VWR, Radnor, PA).  These 
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samples were then sectioned into 8 µm sections utilizing a microtome and the resulting 
ribbon is mounted onto a microscope slide.  These slides can then be stained with 
hematoxylin and eosin to observe ECM orientation, cell penetration and cellular shape.  
Axial sections of the construct were examined using the FibrilTool plugin for the 
ImageJ software suite to determine fiber alignment in terms of anisotropy which returns 
a weighted ratio of alignment [89].  Cross sectional slides were examined to measure 
the distance cells have penetrated into the scaffold and to assess cellular shape, as 
tenocytes should appear as elongated narrow cells.   
4.3.7 Gene Expression 
 Gene expression was measured utilizing real time polymerase chain reaction 
(RT-PCR).  Construct sections are stored in RNA Later solution prior to use.  Sections 
were then cut into pieces and then homogenized utilizing a Ten Broeck tissue grinder 
(Wheaton, Millville, NJ) and Trizol reagent (Life Technologies).  The mRNA can then 
be isolated from the homogenized Trizol solution per the manufacturer’s instructions.  
To remove excess DNA, the RNA solution is treated with DNase (Life Technologies, 
Grand Island, NY) prior to reverse transcription.  Reverse transcription to DNA was 
performed utilizing a RNA-to-cDNA kit (Life Technologies) and Mastercycler ep 
realplex4 (Eppendorf, Hauppauge, NY).  The resulting DNA was then amplified 
utilizing SYBR Green PCR Master Mix (Life Technologies) and specific genes are 
detected utilizing the primers listed in Table 2 [90-97].  Genes in the various 
experimental groups can then be normalized utilizing the housekeeping gene, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and comparison between 
controls and the experimental groups was done utilizing the 2-Ct method of 
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comparing experimental gene targets to the GAPDH housekeeping gene (Ct) and then 
comparing that change to a control (Ct) [98].  
4.4 Sterility Verification 
Unfortunately, a contamination was encountered during bioreactor setup that 
required the disposal of several data groups and the source was not easily identified. 
After the first infection, cell cultures were verified to be infection free and all 
instruments and work stations were sterilized or if unable to be fully sterilized, cleaned 
with bleach and 95% ethanol. Unfortunately repeat infections occurred. Possible causes 
included summer humidity, faulty sterilization, contaminated stock solutions, etc. which 
I investigated. 
4.4.1 HUV Testing 
 The HUV is a primary tissue that when first acquired is not sterile and is 
assumed to be highly contaminated. This was my first instinct as to the source of the 
infection. I sterilized a batch of HUVs normally using the above protocol and then 
washed them in cell culture medium and placed them with the media into T-75 culture 
flasks for 7 days to look for growths. Additionally, I took some of these sterilized 
HUVs and inserted the stainless steel adapters as if they were being inserted into 
bioreactors. I then rinsed them with culture medium and placed them into T-75 cell 






























4.4.2 Chemical Testing 
 Any chemical used in cell culture at any point was tested for contamination. 
Culture medium used in experiments, was placed in culture flasks for 7 days. 4 mL of 
PBS, 4 mL of NaOH stock, and 4 mL of phosphate buffer used to store HUVs were all 
mixed with 6 mL of sterile culture medium. Lastly, 1 mL of 3 mg/mL collagen type I 
was mixed with 9 mL of culture medium. All groups were allowed to incubate for 7 
days and checked for growths.  
4.4.3 Sterilization Verification 
 To verify that my equipment was indeed being properly sterilized, a bioreactor 
was setup following the above protocol with one amendment. The cell injection 
procedure discussed in section 4.3.3 Experimental Design was left out.  
4.4.4 Results 
 The collagen cultures revealed significant visible fungal and bacterial growth 
after 7 days of culture. All other groups showed no detectable living cells. All 
experiments I had previously run using the collagen stock had to be thrown out as the 
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Appendix A: Signal Generator Testing 
 
Figure 7: Wavetek Signal at ~100 Hz 
Sample was recorded in 8 ms. The sine waveform is clearly visible, albeit noisy.  
 
Figure 8: Wavetek Signal at ~0.1 Hz 
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Sample was recorded over 2 min. If a proper waveform was generated, roughly 20 
peaks should be visible.  
 
Figure 9: Wavetek Signal at ~0.01 Hz 
Sample was recorded over 2 min. At 0.01 Hz, 2 clearly defined peaks should be visible.  
